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LymphomaAbstract Background: Increasing capability of MR imaging via applying DWI gives additional
information about the functional state of tissues with high potentials due to lacking radiation
exposure and contrast hazards. Application included evaluation of gastrointestinal tumors and
follow-up to assess response to treatment. In IBD, DWI is useful in highlighting bowel segments
of active disease and the purpose of this study is to evaluate role of DWI-MRI in neoplastic and
inﬂammatory small bowel diseases.
Materials and methods: Prospective study included 50 patients subjected to MRI enterography
using 1.5 T closed magnet followed with DWI and then ADC values were estimated.
Ileo-colonoscopy and biopsy were done and pathological data were reviewed.
Results: Twenty-four males and 26 females with small bowel lesions were divided into two groups,
26 neoplastic (5 benign, 21 malignant) and 24 inﬂammatory lesions (48%). Mean ADC value of
inﬂamed bowel was 1.59 ± 0.45  10–3 mm2/s, compared to 2.74 ± 0.68  10–3 mm2/s in normal
bowel. ADC value of neoplastic lesions ranged from 0.6 to 1.5 and non-neoplastic lesions from
1.1 to 2. ADC value of lymphoma ranged from 0.6 to 0.7  10–3 mm2/s and adenocarcinomas from
0.8 to 1.0  10–3 mm2/s.
Conclusion: DWI is an important complementary sequence with the routine MRI of the small
bowel helping in lesion characterization and differentiation of pathology.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
The process by which water molecules can move freely in
different biological tissues is due to random translational
‘‘Brownian”motion, so diffusion weighted magnetic resonance
imaging (DWMRI) is considered the recent imaging technique
that assesses this process of diffusion in vivo. Calculating
860 A.H. Aﬁﬁ et al.ADCs ‘‘apparent diffusion coefﬁcient” considered the quanti-
tative way to express the degree of diffusion in biological
tissues (1).
Tissue cellularity and integrity of cell membrane both esti-
mate the degree of diffusion restriction and so pathological
tissues as in case tumors or inﬂammation exhibited increased
cell numbers that result in increased intracellular space in a
given volume and consequently presented with diffusion
restriction. Multiple previous studies proved also that mea-
sured ADC values decreased with increased tissue cellularity
or cell density and in turn DW MRI is considered a sensitive
tool in differentiating nature of histopathological tissues (2,3).
DWI in the last decade was considered an important com-
plementary MRI technique in imaging of the abdomen and
more especially the pelvis. Most malignancies affecting GIT
demonstrated increased cellularity compared with normal tis-
sues and so resulted in diffusion restriction with increased sig-
nal intensity on DWI (4). Recent previous researches showed
that malignant GIT tumors have low ADC values compared
with related normal tissue or benign lesions (4,5).
Recently, DWI may play a role in quantiﬁcation of inﬂam-
matory process as inﬂamed bowel segments exhibited
restricted diffusion compared with normal bowel (6,7). Also
DWI can provide quantitative information about the level
and activity of inﬂammation, whether acute or chronic inﬂam-
mation, as the apparent diffusion coefﬁcient (ADC) can be
calculated from the bowel wall (8).
Practically, main indications for applying DWI are the
diagnostic evaluation of neoplastic lesions regarding localiza-
tion and staging in case of malignant GIT tumors. Other appli-
cations are assessing extra-intestinal spread, distant metastases
and post-therapy follow-up of malignant tumors (9,10).
In application in cases with inﬂammatory bowel disease,
DWI is useful in highlighting bowel segments of active disease
and hence it is becoming a standard component of the MR
enterography protocol; however, further studies are manda-
tory to assess the full potential of this technique and guide
its clinical applications (10).
Nephrogenic systemic ﬁbrosis was considered as a rare but
serious complication of Gadolinium-based contrast agents,
that aid the direction for diminished use of intravenous con-
trast agents in MR imaging, and so DWI become an important
alternative method to obtain information that could otherwise
be obtained from extracellular contrast enhancement (11).
A new possibility to expand the capability of MR imaging
was to apply new MR application, namely DWI, that could
give more information about the structure and function of
the involved bowel with its high potentials due to lack of
exposure to radiation and contrast hazards (12).
Most of the available published descriptions of DWI for the
evaluation of the bowel were focused on the detection of
colorectal cancer (13).
To our knowledge, the use of DWI for evaluation of bowel
wall masses and inﬂammation had been previously described
in minor degree.2. Purpose
The purpose of the current work is to assess the role of DW
MRI sequence in diagnosis and evaluation of different
inﬂammatory and neoplastic small bowel diseases.3. Material and methods
Fifty patients were included in the current prospective study,
during interval from December 2013 to March 2015 with
suspected small bowel lesions, who were referred to multiple
radiology centers, mainly for CT abdomen or CT entero-
colonography ‘‘CTE” examination and consequently, they
were scheduled for further assessment by complementary
MRI and DW MRI in order to conﬁrm the CT diagnosis
(whether MRI and DWI would be in concordance with CTE
diagnosis) or in a trial to reach the ﬁnal diagnosis. Medical
ethics were considered and patients were aware of the exami-
nation, and patient’s agreement was obtained with informed
consent.
Only patients with positive CTE as known or suspected
small bowel disease were included. Also included were group
of patients in whom intravenous CT contrast injection was
contraindicated due to poor renal functions (5 patients),
whereas exclusion criteria included general contraindications
to MRI e.g. presence of cardiac pacemakers, surgical clips in
the abdomen and pelvis that can result in extensive artefacts
based on their composition.
The studied patients had full history taking, thorough clin-
ical examination. Radiological examination included routine
abdominal US survey that was done for all patients to detect
any other abdominal GIT abnormalities as focal hepatic
lesion, lymphadenopathy or ascites.
MD CT enterography (either 16 or 64 slices) followed with
abdominal MRI concerning the small bowel (i.e. MR
enterography) was performed for all patients using 1.5 T
superconducting closed magnet MRI followed with DWI.
Ileo-colonoscopy and biopsy (endoscopic or imaging guided)
were done for indicated patients, and then pathological data
of all patients were reviewed.
3.1. MRI and DWI technique
Patient preparation: Patients being fasting for at least 6 h, and
then were ingested with 1200–1300 mL of an iso-osmotic solu-
tion of mixed water and mannitol to produce a 3% solution
(mannitol 10% diluted with water in a ratio of 1:1 in order
to be iso-osmotic). This was divided into two aliquots of
600–650 mL each, and the patient drank one aliquot every
25–30 min. Another 200 mL of the solution was given just
before scanning to opacify the stomach and duodenum.
10 mg of hyoscine butylbromide (Buscopan) was injected IV
to eliminate peristalsis and reduce motion artifact.
MRI examination: Patients were requested to lie in the
supine position, arms extended above head and phased array
surface coil was used. Respiratory-gated acquisitions were
used in some sequences. Typical scan time of all sequences
was 20–30 min. In cases of contrast study, IV line was con-
nected to an automated power injector ﬁlled with the appropri-
ate dose of contrast which comprised of 0.1 mmol (0.2 mL) of
gadolinium chelate per kilogram of body weight (gadopente-
tate dimeglumine; Magnevist, Bayer HealthCare) at
rate = 3 mL/s. The importance of remaining stable during
study was emphasized.
MRE scanning sequences included initial localizer T1-W
GRE sequences were used, followed with single breath-hold
Coronal T2-weighted sequence (HASTE), Axial and Coronal
ROC Curve



























Fig. 2 ROC curve to diagnose adenocarcinoma lesions.
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T1-weighted 3D gradient echo (VIBE). Post-contrast VIBE
sequences obtained in Coronal and Axial planes. DWI with
variable b values 0,400 and 800 s/mm2 with TR 2000, TE 80,
ﬂip angle 90, FOV 370 mm, slice thickness 6 mm and average
scan time 75 s with automatically computer-generated ADC
map. We applied high b values (b> 800–1000 s/mm2) for
imaging bowel segments and to suppress signals from
bowel contents and contrast materials which yielded T2
shine-through artifact. Source images were transferred to a
dedicated workstation for post-processing.
3.2. Interpreting diffusion-weighted images
(1) Qualitative analysis: DWI were viewed to assess signal
intensity whether there is diffusion restriction in abnor-
mal tissue (e.g. inﬂammatory, abscess or tumor) result-
ing in hyper-intensity on DWI and of low signals on
ADC maps.
(2) Quantitative analysis: Mean ADC values of different
tissues were calculated. Areas of most restricted diffu-
sion (ROI i.e. region of interest) have low ADC values.
DWI was interpreted in correlation with ADC map and
then ADC values were calculated in 103 mm2/s.
4. Results
Current study included 50 cases divided as 24 males (48%) and
26 females (52%). Small bowel lesions were subdivided based
upon the ﬁnal diagnoses into two groups, 26 small bowel neo-
plastic lesions (52%) (including 5 benign and 21 malignant
tumors) and 24 inﬂammatory lesions (48%) with different
stages of chronicity. Renal insufﬁciency was found in ﬁve
patients where CT and MRI were done without contrast
administration.
Malignant lesions included 9 lymphoma, 8 adenocarci-
noma, 3 gastrointestinal stromal tumors GIST and one carci-
noid tumor. Benign lesions (5 patients) were benign
adenomatous polyps. Neuroﬁbromatosis type I was found in
one case presented with terminal ileum GIST and ‘‘Cafe´-au-l
ait” ﬂat and pigmented skin spots ‘‘hallmark of NF”. Inﬂam-
matory group included inﬂammatory bowel diseases (active
Crohn’s disease 15 cases, chronic non-active Crohn’s 5 cases),
3 cases were non-speciﬁc inﬂammation and one case was T.B
ileitis.
The mean age was 54.7 ± 12.9 years ranging from 24 to
78 years in neoplastic lesions and was 33.4 ± 10.6 years rang-
ing from 18 to 55 years in non-neoplastic lesions. The main
patients’ presentations included abdominal pain in 40 patients
(80%); followed by chronic diarrhea in 12 patients (24%);
weight loss in 6 patients (12%); hematochezia in 3 patients
(6%); constipation in 3 patients (6%); jaundice in 2 patients
(4%) and one patient presented with melena (2%).
The ﬁnal diagnosis had been conﬁrmed by ileo-colonoscopy
and biopsy in 29 lesions (58%), Upper GI endoscopy and
biopsy in 7 lesions (14%), ultrasound guided biopsy in 3
lesions (6%), ERCP in 2 lesions (4%), surgical exploration
in 2 lesions (4%) and the remaining in 7 lesions (12%), and
the ﬁnal diagnosis was achieved with radiological ﬁndings
and supported by clinical data.4.1. MRE and DWI findings
Group A patients include 26 (52%) neoplastic lesions.
MRI and DWI of small bowel lymphoma: This was diag-
nosed in 9 patients (one duodenal, two jejunal, three ileal
and three in terminal ileum and ileo-cecal). Gross patterns
included polypoidal (ﬁve lesions), inﬁltrating (two lesions),
and diffuse wall thickening with lost parietal folds (two
lesions).
Radiological features were aneurysmal dilation of the
lumen ‘‘due to local neuropathy” in eight lesions (as in
Case 1), large exo-enteric mass extending beyond bowel wall
(two lesions) and circumferential inﬁltration was eccentric,
with the absence of a distinct mesenteric or anti-mesenteric
distribution in 5 lesions. Lymphoma typically demonstrated
Case 1 55 years female patient pathologically proven jejunal lymphoma (A) Coronal HASTE fat sat, (B) Axial true-FISP and (C)
Coronal post-contrast VIBE fat sat showed long segmental homogenously enhancing soft tissue mural thickening at distal jejunum with
‘‘aneurysmal bowel dilatation.” (D) and (E) DWI and ADC showed diffusion restriction (arrow in D) with ADC value averaging
0.63  10–3 mm2/s matching with pathological diagnosis.
862 A.H. Aﬁﬁ et al.homogenous mild enhancement in seven lesions and moderate
heterogeneous enhancement in two lesions. Lymphomatous
inﬁltrations in liver (two lesions), lung, kidney and spleen
(one lesion) and mesenteric lymph nodes (5 lesions). All lym-
phoma cases showed avid diffusion restriction and ADC value
ranging from 0.6 to 0.7  103 mm2/s.
MRI and DWI of small bowel adenocarcinoma: This was
diagnosed in eight patients where MRI showed heterogeneousenhancing luminal duodenal cauliﬂower mass (in two
patients), diffuse trans-mural inﬁltration of jejunal wall with
exophytic growth and accompanied with eccentric bowel wall
thickening in two patients (Case 2), and terminal ileal lesions
appeared as inﬁltrative lesions, causing luminal stenosis and
obstruction with pre-stenotic dilatation in three patients
(Case 3). Two lesions in terminal ileum and ileo-cecal valve
involvement showed a local soft tissue mass (one with omental,
Case 2 56 years female patient had pathologically proven jejunal adenocarcinoma with ulceration and perforation (A) Coronal, (B)
Axial true-FISP and (C) Coronal post-contrast VIBE fat sat with enhanced circumferential irregular mural annular thickening of the
proximal jejunum with mild localized free ﬂuid collection (arrow in B) related to its medial aspect. (D) and (E) DWI and ADC showed
diffusion restriction with ADC value averaging 0.8  103 mm2/s.
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864 A.H. Aﬁﬁ et al.one with liver metastasis). General MRE features as sharply
demarcated, circumferential luminal narrowing, with shoulder-
ing of the margins and mucosal destruction. Post-gadolinium
MRE demonstrated mildly enhancing heterogeneous eight
lesions. All cases showed diffusion restriction and ADC values
ranging from 0.8 to 1  103 mm2/s.
MRI and DWI of small bowel GIST: This was diagnosed in
three patients: two at terminal ileum and one at distal jejunum.
Hallmarks of diagnosis is the exophytic growth nature due to
serosal origin with signiﬁcant mass effect (Case 4). The
boundary of the lesion was more distinct after contrast.
Malignant GISTs are predominantly extra-luminal, eccentric
and frequently develop necrosis and hemorrhage. One of these
cases was associated with Neuroﬁbromatosis type I (NF1)
(Case 5), and showed diffusion restrictions with ADC value
averaging 0.83  103 mm2/s. The other two cases showed dif-
fusion restriction with ADC value averaging 0.8  103 mm2/s
and 0.88  103 mm2/s.
MRI and DWI of small bowel carcinoid: This was diagnosed
in one case with no speciﬁc MRI features as CT enterography
was superior in detecting the primary lesion, desmoplastic
reaction and calciﬁcation rather than MRI. DWI shows mildCase 3 28 years male had pathologically proven ileal adenocarcinoma
segmental tumifactive circumferential thickening resulting in manife
diffusion restriction (red arrow in C) with ADC value averaging 0.82restriction as well as comparatively high ADC compared with
other lesions ADC value 1  103 mm2/s.
Group B patients: This group included IBD that was diag-
nosed in 20 patients (12 conﬁned to the small bowel and 8
had ileo-colonic disease). Seventeen had speciﬁc inﬂammatory
disease (16 Crohn’s disease and one TB) and three with non-
speciﬁc inﬂammatory diseases.
Features of active Crohn’s disease: Case 6 showed uniform
mural thickening more than 3 mm, high T2-signals (due to
edema), and engorged related vasa recta (Comb’s sign) in 11
patients. Post-contrast enhancement of the bowel wall (strati-
ﬁcation with target pattern) was found with enhanced local
mesenteric adenopathy. Luminal affection was found either
as non-constricted bowel lumen in 11 patients, or stenosis with
pre-stenotic dilatation in 4 patients in the terminal ileum
(namely ﬁbro-stenotic type). Features of chronic Crohn’s dis-
ease were creeping fat and ﬁbro-fatty proliferation (4 patients
with skip lesions). Complications are ileo-ileal and ileo-colic
ﬁstula (in 2 patients) and peri-anal ﬁstula in one patient (pen-
etrating type). Pelvic abscess occured in two lesions. Bowel seg-
ments with active inﬂammation showed more diffusion
restriction in comparison with normal bowel segments, which(A) HASTE Coronal, (B) Axial true FISP showed irregular short-
st luminal stenosis (straight arrow), (C) and (D) DWI showed
 103 mm2/s.
Case 4 70 years male patient had pathologically proven ileal and ileo-cecal adenocarcinoma. (A) and (B) Coronal true-FISP with fat sat
showed uniform mural thickening of the terminal ileum (curved white arrow in A) with exophytic soft tissue mass (star in B) associated
with multiple omental deposits (straight white arrows in A). (C) and (B) DWI and ADC showed diffusion restriction of the omental
deposits (red arrows).
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sity on DWI) and quantitative manners (as decreased ADC
values).
Mean ADC value of proven inﬂamed bowel segments was
1.59 ± 0.45  103 mm2/s (range, 1.1–2.0  103 mm2/s),
compared to 2.74 ± 0.68  103 mm2/s (range, 2–4.03 
103 mm2/s) in normal bowel segments. On the other hand,
ADC value of neoplastic lesions ranged from 0.6 to
1.5  103 mm2/s while that of the non-neoplastic lesions from
1.1 to 2.0  103 mm2/s. Low ADC value in non-neoplastic
lesions was due to pelvic abscess with increased viscosity which
decreases the diffusibility rather than cellularity.
Statistical analysis of ADC value in diffusion MRI among
the studied neoplastic and non-neoplastic patients was
presented in Table 1. The cutoff value of ADC for
non-neoplastic lesion was 1.05  103 mm2/s, so lesions with
ADC less than 1.05  103 mm2/s are neoplastic while lesions
with ADC value more than 1.05  103 mm2/s are non-
neoplastic with a sensitivity of 100%; speciﬁcity of 88.5%
and PPV = 87.5%, NPV = 100%, area under curve = 0.963.Receiver operating characteristic (ROC) curve of the cutoff
ADC value used for differentiating non-neoplastic from neo-
plastic lesions of small bowel disease = 1.05  103 mm2/s,
sensitivity = 100%, speciﬁcity = 88.5%, area under the curve
(AUC) = 0.963 (Fig. 1).
ADC value of lymphoma ranged from 0.6 to
0.7  103 mm2/s while that of the adenocarcinomas lesions
ranged from 0.8 to 1.0  103 mm2/s. Statistical analysis of
ADC value in diffusion MRI among the studied patients with
lymphoma and adenocarcinoma lesions was presented in
Table 2.
Receiver operating characteristic (ROC) curve of the cutoff
ADC value used for differentiating adenocarcinoma from lym-
phoma lesions of small bowel tumors = 0.75  10–3 mm2/s,
sensitivity = 100%, speciﬁcity = 100%, area under the curve
(AUC) = 1 (Fig. 2).
The cutoff value of ADC for adenocarcinoma is
0.75  103 mm2/s, so lesions with ADC less than
0.75  103 mm2/s are lymphoma while lesions with ADC
value more than 0.75  103 mm2/s are adenocarcinomas with
Case 5 59 years female old patient had pathologically proven GIST. (A) CTE Coronal post-contrast showed homogenously enhancing
exophytic mass, (B) Axial true-FISP fat sat showed small areas of cystic necrosis (arrow in B), (C) and (D) DWI and ADC showed
diffusion restriction with ADC value averaging 0.88  103 mm2/s.
866 A.H. Aﬁﬁ et al.a sensitivity of 100%; speciﬁcity of 100% and PPV = 100%,
NPV = 100%. Area under curve = 1.0.
5. Discussion
DWI of the small bowel used in evaluation of primary GIT
neoplasms as detection, assessment of extra-intestinal spread
and detection of distant metastases, also in identifying actively
inﬂamed loops of bowel in cases of inﬂammatory bowel
diseases; this was approached by the presence of restricted
diffusion within the tumor lesion or active inﬂammation in
the affected bowel wall. It gives both qualitative and quantita-
tive information about tissue cellularity as well as integrity of
cell membranes (14).
Ichikawa et al. (14) stated that DWI with high b value of
1000 s/mm2 provided 90.9% sensitivity and 100% speciﬁcity
for detecting colorectal cancers. In this series of 42 patients
with sigmoid and rectal carcinoma, all tumors were clearly
demarcated from both normal bowel wall and bowel lumen,
which were always hypo-intense on DWI.
Current study demonstrated that on DW images with high
b value, malignant lesions exhibited high signal intensity with
low ADC values due to high cellular contents, diminished
extracellular space, and tissue disorganization resulting in
restricted diffusion. The cutoff value of ADC for non-
neoplastic lesion was 1.05  103 mm2/s, so lesions with
ADC less than this value were considered neoplastic while
lesions more than 1.05  103 mm2/s were non-neoplastic with
a sensitivity of 100%; speciﬁcity of 88.5% and PPV = 87.5%,
NPV = 100%.For further speciﬁcation, also noted that cutoff value of
ADC for differentiating lymphoma from adenocarcinoma
was 0.75  103 mm2/s, where cases with ADC less than
0.75  103 mm2/s were lymphoma while those with ADC
value more than 0.75  103 mm2/s were adenocarcinoma
with a sensitivity of 100%; speciﬁcity of 88.5% and
PPV = 100%, NPV = 100%.
We were in agreement with the results of new study per-
formed by Feuerlein et al. (4) who stated that majority of
GIT malignancies demonstrated high cellularity than normal
tissues and hence showed restricted diffusion than normal
tissues.
Also, DWI can help in differentiation between recurrent
cancer and secondary post-radiotherapy changes, by
estimating related ADC values, where high ADC and no
diffusion restriction matching with tissue edema 2ry to
post-radiation therapy and low ADC indicating recurrent
tumor. Here, DWI technique will be advantageous over PET
as the later will be of limited use after short time of radiation
therapy due to increased uptake due to inﬂammation and
edema (12).
Regarding Crohn’s disease and ulcerative colitis, the active
bowel inﬂammation showed inﬁltrated lamina propria and
submucosa by inﬂammatory and lymphocytic cells resulting
in increased cellularity, viscosity and granulation tissue leading
to restricted diffusion (6,13).
Complications of inﬂammatory bowel disease as abscess
formation as well as ﬁstula, and sinus formation could be
traced at DWI, leading to high accuracy for diagnosing
intra-abdominal abscesses (15).
Case 6 24 years female patient had pathologically proven active Crohn’s disease of penetrating subtype (A) Sagittal HASTE, (B) Axial
post-contrast VIBE fat sat showed complex ileo-ileal and ileo-colic ﬁstula as multiple adherent bowel loops in a stellate conﬁguration (star
sign), increased signal of the bowel wall in the HASTE image is consistent with bowel wall edema and denoting activity. Stratiﬁed target
enhancement pattern seen in (B). Images (C) and (D) DWI and ADC showed diffusion restriction with ADC value averaging
1  103 mm2/s.
Table 1 Diffusion MRI among the studied patients with neoplastic and non-neoplastic lesions.
Diﬀusion of MRI Non-neoplastic lesion (n= 24) Neoplastic lesion (n= 26) Signiﬁcance
No. % No. %
Restricted DWI
No restriction 2 8.3 0 0.0 FEP= 0.103
Restriction 22 91.7 26 100.0
ADC value
Min–max 1.1–2.0 0.6–1.5 t= 8.427
Mean ± SD 1.5 ± 0.3 0.9 ± 0.2 P< 0.0001*
FEP: Fisher’s exact test.
t: t-test.
* Signiﬁcant at P 6 0.05.
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tion as a result of its high viscid ﬂuid contents rich in bacteria,
inﬂammatory cells, and cellular debris. Also ﬁstulas and sinus
tracks expressed high signals on DWI, again, because of pus,
inﬂammatory cells, and debris in and around the ﬁstula tract.Pus contents showed high viscosity with packed inﬂamma-
tory cells, both were resulted in diffusion restriction which
appears as increased signal intensity on DWI.
Even pattern of restriction helped in differentiating abscess
from necrotic neoplasm as in cases of GIST, where restriction










Min–max 0.6–0.7 0.8–1.0 Z= 3.527
Mean ± SD 0.7 ± 0.05 0.9 ± 0.08 P< 0.0001*
Z: Mann Whitney test.
* Signiﬁcant at P 6 0.05.
868 A.H. Aﬁﬁ et al.in abscess was in the central trapped pus while in necrotic neo-
plasm it shows restriction along the residual peripheral solid
portion, which was in agreement with Schmid-Tannwald
et al. (16).
Kiryu et al. (17) and Oto et al. (13) stated that DWI
expressed high sensitivity (86–94%) and speciﬁcity (81.4–
84.8%) for diagnosing active inﬂammatory bowel disease.
Applying ADC threshold of 2.4  103 mm2/s, Oto et al.
(6) reported that DWI presented 94% sensitivity and 88%
speciﬁcity in distinguishing normal and inﬂamed bowel and
this value concomitantly was agreed with our results that
added that inﬂamed bowel segments showed more diffusion
restriction in comparison with normal bowel segments.
Low et al. (18) added the high diagnostic accuracy of DWI
for detecting early peritoneal deposits especially when com-
bined with dedicated MRI study using oral and IV contrast.
In the current study, this was signiﬁcantly noted in limited
number of cases and we recommend to apply it in special sep-
arate study using wider scale of patients having different
malignant abdominal primaries that suspected to have peri-
toneal deposits.
Regarding characterization of metastatic lymphadenopathy
in the current study, pelvi-abdominal lymph nodal deposit
showed high signals on DWI with low ADC values. Consider-
able overlap existed between ADC values between benign and
malignant lymph nodes; however, Feuerlein et al. (4) and
Kyriazi et al. (19) stated that nodal metastasis had lower
ADC values as compared to benign ones.
Vandecaveye et al. (20) presented ADC threshold value of
1.0–1.38  103 s/mm2 with more than 90% sensitivity and
speciﬁcity to differentiate metastatic from normal lymph nodes
in the primary malignancies of head and neck.
We were in agreement with Sinha et al. (21) who stated that
DW MRI considered powerful tool to increase the diagnostic
accuracy as it can depict abnormality of the gastrointestinal
tract, and so it could help in the diagnosis of the primary lesion
and depict distant metastases in patients with known GIT
malignancies.
The advantages of MRI over CT in general included the
elimination of ionizing radiation and hence the only tool in
pregnant patients and the preferred tool in children, it has
the high diagnostic performance in patients with impaired
renal function. If necessary, the non-contrast MR examination
could be performed, with high accuracy for patients with a
contrast allergy or low glomerular ﬁltration rate who were at
risk for nephrogenic systemic ﬁbrosis.
In the described cases, DWI helped in quantiﬁcation of
inﬂammatory changes as well as the related complications with
no need of contrast material administration. This qualitative
information helped to assess response to treatment in patientswith malignant small bowel lesion. DWI helped to assess
degree and activity of bowel inﬂammation as well as estimated
response as regards inﬂammatory bowel disease (IBD). Multi-
ple studies discussed its help in predicting treatment response
by estimating ADC values before management of tumors.
Complications of inﬂammation, such as malignant changes,
abscess, and ﬁstula might also be depicted (22).
Considering DWI as a part of standard MR imaging, no
additional technique or machine is needed as it can be added
to the routine MR protocol, but common limitations of both
MRI and DWI take long time of the study performance and
interpretation as compared with CT enterography (11).
6. Conclusion
DWI is an important complementary sequence with the rou-
tine MRI of the small bowel that helps in lesion quantiﬁcation
and characterization in a hope to reach ﬁnal conﬁdent diagno-
sis and in order to reduce the rate of biopsy. Also DWI may be
used as a monitoring tool in follow-up for the response to
therapy.Conﬂict of interest
The authors declared that there is no conﬂict of interest.
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